BioCardia (BCDA) CEO Altman has RSU tax shares withheld, receives new option grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
BioCardia, Inc. President and CEO Peter Altman reported routine equity compensation activity. On July 2, 2026, 54,606 shares of common stock were withheld by the company at $1.24 per share to cover income tax obligations on vested RSUs, and this did not represent a market sale by Altman. Following this tax-withholding disposition, he directly held 356,585 common shares. On July 6, 2026, he received a grant of stock options for 57,688 shares of common stock at a $1.20 exercise price, expiring on July 6, 2036, with vesting in 1/48th monthly installments beginning August 6, 2026, contingent on continued service, resulting in 147,903 options held after the grant.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Altman Peter
Role
President and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 57,688 | $0.00 | -- |
| Tax Withholding | Common Stock | 54,606 | $1.24 | $68K |
Holdings After Transaction:
Stock Option (right to buy) — 147,903 shares (Direct, null);
Common Stock — 356,585 shares (Direct, null)
Footnotes (1)
- The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement on July 2, 2026, of the RSUs vested on June 29, 2026 and does not represent a sale by the Reporting Person. The option vests and becomes exercisable as to 1/48th of the shares on August 6, 2026, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.
Key Figures
RSU tax-withholding shares: 54,606 shares
Withholding reference price: $1.24 per share
Post-transaction common shares: 356,585 shares
+4 more
7 metrics
RSU tax-withholding shares
54,606 shares
Common stock withheld on July 2, 2026 to satisfy tax obligations
Withholding reference price
$1.24 per share
Price used for 54,606 common shares withheld for tax obligations
Post-transaction common shares
356,585 shares
Common stock directly held after July 2, 2026 tax-withholding disposition
New option grant size
57,688 options
Stock options granted on July 6, 2026 over common stock
Option exercise price
$1.20 per share
Exercise price for 57,688 newly granted stock options
Option expiration date
July 6, 2036
Expiration for newly granted stock options
Post-grant options held
147,903 options
Total stock options held following the July 6, 2026 grant
Key Terms
RSUs, net settlement, stock option, income tax, withholding and remittance obligations, +1 more
5 terms
RSUs financial
"the net settlement on July 2, 2026, of the RSUs vested on June 29, 2026"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
net settlement financial
"in connection with the net settlement on July 2, 2026, of the RSUs vested"
stock option financial
"The option vests and becomes exercisable as to 1/48th of the shares"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
income tax, withholding and remittance obligations financial
"withheld by the Issuer to satisfy its income tax, withholding and remittance obligations"
vests and becomes exercisable financial
"The option vests and becomes exercisable as to 1/48th of the shares on August 6, 2026"
FAQ
What insider transactions did BioCardia (BCDA) report for Peter Altman?
BioCardia reported that CEO Peter Altman had 54,606 shares withheld to cover tax obligations on vested RSUs and received a grant of 57,688 stock options at a $1.20 exercise price, expiring in 2036, as part of his equity compensation.
What are the terms of Peter Altman’s new BioCardia stock option grant?
Peter Altman was granted options for 57,688 shares of BioCardia common stock at a $1.20 exercise price, expiring July 6, 2036. The options vest monthly in 1/48th increments starting August 6, 2026, subject to his continued service with the company.